Studying endothelial damage in COVID-19
Menarini Silicon Biosystems, a leader in the field of rare cells isolation and analysis, has put in place its resources to contribute advancing the knowledge on COVID-19.
COVID-19 is often associated with cardiovascular complications and endothelial damage. Studies have shown that the number of endothelial cells that are circulating in the bloodstream (CECs) can be a specific and sensitive marker of endothelial damage and could help identify the most severe COVID-19 cases.
Menarini Silicon Biosystem’s CELLSEARCH® platform, in combination with the CELLSEARCH® Circulating Endothelial Cell Kit*, is able to capture and enumerate CECs in peripheral blood and ongoing studies are aimed at demonstrating that enumeration of CECs is a potential biomarker of cardiovascular complications.
* For Research Use Only. Not for use in diagnostic procedures. The performance characteristics, safety, and effectiveness have not been established and are not cleared or approved by the FDA.